Jillian B. Thomsen

NKTR

Jillian B. Thomsen serves as Chief Financial Officer at Nektar Therapeutics (NKTR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

8 trades

$647.1K

Net Position

Net Seller

$647.1K

Companies Traded

NKTR

Active Period

May 2021 – Feb 2023

8 total trades

Most Recent

Sell NKTR

Feb 17, 2023 · $30.8K

Jillian B. Thomsen's Insider Trading at Nektar Therapeutics (NKTR)

Buys

0 · $0.00

Sells

8 · $647.1K

Total Shares Bought

Total Shares Sold

65,043

NKTR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 17, 2023	Sell	10,267	$3.00	$30.8K	313,497
Nov 18, 2022	Sell	11,095	$3.57	$39.6K	323,764
Aug 17, 2022	Sell	2,006	$4.76	$9.5K	334,859
May 17, 2022	Sell	5,841	$3.95	$23.1K	170,427
Feb 18, 2022	Sell	2,363	$10.95	$25.9K	165,318
Nov 17, 2021	Sell	6,741	$13.16	$88.7K	145,981
Aug 18, 2021	Sell	13,339	$13.83	$184.5K	137,822
May 19, 2021	Sell	13,391	$18.30	$245.1K	151,161

Related Insiders

ROBIN HOWARD W

President & CEO

NKTRSell · Feb 18, 2026

Jonathan Zalevsky

officer: Chief R&D Officer

NKTRSell · Feb 18, 2026

Mark Andrew Wilson

Chief Legal Officer

NKTRSell · Nov 25, 2025

Explore More Insider Trading Data

NKTR Insider Trading Activity

View all insider trades at Nektar Therapeutics

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity